Global Differences in Burden and Treatment of Ischemic Heart Disease in Acute Heart Failure-Reference-Cited by-同舟云学术

Global Differences in Burden and Treatment of Ischemic Heart Disease in Acute Heart Failure

Published:2021-05 Issue:5 Volume:9 Page:349-359
ISSN:2213-1779
Container-title:JACC: Heart Failure
language:en
Short-container-title:JACC: Heart Failure

Author:

Tromp Jasper,Ouwerkerk Wouter,Cleland John G.F.,Angermann Christiane E.,Dahlstrom Ulf,Tiew-Hwa Teng Katherine,Bamadhaj Sahiddah,Ertl Georg,Hassanein Mahmoud,Perrone Sergio V.,Ghadanfar Mathieu,Schweizer Anja,Obergfell Achim,Filippatos Gerasimos,Collins Sean P.,Lam Carolyn S.P.,Dickstein Kenneth

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference24 articles.

1. Significance of ischemic heart disease in patients with heart failure and preserved, midrange, and reduced ejection fraction: a nationwide cohort study;Vedin;Circ Hear Fail,2017

2. Relationship between angina pectoris and outcomes in patients with heart failure and reduced ejection fraction: an analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA);Badar;Eur Heart J,2014

3. Coronary artery disease and outcome in acute congestive heart failure;Purek;Heart,2006

4. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey;Yusuf;Lancet,2011

5. High-quality health systems in the Sustainable Development Goals era: time for a revolution;Kruk;Lancet Glob Heal,2018

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipoprotein(a) as a novel biomarker for predicting adverse outcomes in ischemic heart failure;Frontiers in Cardiovascular Medicine;2024-09-05

2. Differential Prognostic Impact of Risk-Prediction Models for Heart Failure in Acute Myocardial Infarction: The Original and Revised Heart Failure Time-Points;Journal of Clinical Medicine;2024-04-24

3. Regional Differences in the Epidemiology of Heart Failure;Korean Circulation Journal;2024

4. Health care costs of cardiovascular disease in China: a machine learning-based cross-sectional study;Frontiers in Public Health;2023-11-06

5. Redirecting immune, lipid, and metabolic drivers of early cardiovascular disease: the RESET cohort study and randomized trial;European Heart Journal;2023-09-07